期刊
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
卷 24, 期 15, 页码 8772-8778出版社
WILEY
DOI: 10.1111/jcmm.15511
关键词
electroporation; endothelial progenitor cells; ex vivo cell therapy; gene therapy; beta-amyloid disaggregation
资金
- Tufts Biolabs Launchpad, Boston, MA
In neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, multiple sclerosis and amyotrophic lateral sclerosis, neuroinflammation can lead to blood-brain barrier (BBB) breakdown. After intravenous or intra-arterial injection into mice, endothelial progenitor cells (EPCs) home to the damaged BBB to promote neurovascular repair. Autologous EPCs transfected to express specific therapeutic proteins offer an innovative therapeutic option. Here, we demonstrate that EPC transfection by electroporation with plasmids encoding the reporter protein GFP or an anti-beta-amyloid antibody fragment (Fab) leads to secretion of each protein. We also demonstrate the secreted anti-beta-amyloid Fab protein functions in beta-amyloid aggregate solubilization.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据